Durham pharma Novan to sell assets in bankruptcy case
Durham drugmaker Novan has agreements in place to sell its assets as the company’s bankruptcy moves forward.
Read More
Mayne Pharma
Huge drug manufacturing operation in Greenville is sold for $475 million
Metrics Contract Services, which is owned by Mayne Pharma Group Limited of Australia, operates a 333,000-square-foot facility in Greenville. It includes 16 manufacturing suites, with 11 that can handle high-potency compounds, as well as two packaging lines to support a variety of development and commercial supply programs.
Read More
Psoriasis treatment from Mayne Pharma, which has big NC operations, receives FDA approval
Mayne Pharma, which has major U.S. facilities in Raleigh and Greenville, earns FDA approval for its product to treat moderate to severe plaque psoriasis in patients 12 and older.
Read More
Metrics Contract Services adds more production space at Greenville campus
Metrics Contract Services, a full-service global contract development and manufacturing organization (CDMO) based in Greenville, has expanded its facilities for producing oral, solid-dose drugs.
Read More
Plant-based oral contraceptive to be marketed by Mayne Pharma approved by FDA
A Greenville pharmaceutical company is poised to manufacture a new plant-based oral contraceptive as soon as June, now that the drug is approved by the U.S. FDA.
Read More
